India - English - Central Drugs Standard Control Organization

kivi hc. - prochlorperazine,paracetamol,ergotamine,caffeine - tab - 2.5,250,1,100;mg - 10

India - English - Central Drugs Standard Control Organization

kivi hc. - flupenthixol,melitracen - tab - 0.5,10;mg - 10

India - English - Central Drugs Standard Control Organization

kivi hc. - flunarizine - 10mg - 10

India - English - Central Drugs Standard Control Organization

kivi hc. - risperidone,trihexyphenidyl - tab - 3,2;mg - 10

European Union - English - EMA (European Medicines Agency)

ipsen pharma - mecasermin - laron syndrome - pituitary and hypothalamic hormones and analogues - for the long-term treatment of growth failure in children and adolescents with severe primary insulin-like-growth-factor-1 deficiency (primary igfd).severe primary igfd is defined by:height standard deviation score ≤ -3.0 and;basal insulin-like growth factor-1 (igf-1) levels below the 2.5th percentile for age and gender and;growth hormone (gh) sufficiency;exclusion of secondary forms of igf-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids.severe primary igfd includes patients with mutations in the gh receptor (ghr), post-ghr signalling pathway, and igf-1 gene defects; they are not gh deficient, and therefore, they cannot be expected to respond adequately to exogenous gh treatment. it is recommended to confirm the diagnosis by conducting an igf-1 generation test.

European Union - English - EMA (European Medicines Agency)

allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

European Union - English - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Canada - English - Health Canada

pharmascience inc - glyburide - tablet - 5mg - glyburide 5mg - sulfonylureas

Canada - English - Health Canada

pharmel inc - glyburide - tablet - 5mg - glyburide 5mg - sulfonylureas

Canada - English - Health Canada

pharmascience inc - glyburide - tablet - 5mg - glyburide 5mg - sulfonylureas